CV Sciences Inc (CVSI)

[Art Vandeley]

Joshua Hartsel Bio



Dr. Joshua Hartsel specializes in medicinal organic chemistry. He earned his Ph.D. at Virginia Tech designing safe insecticide targets to combat the African malaria mosquito. A successful hit to lead optimization strategy culminated in the identification 6 novel ligands with an unprecedented level of enzyme selectivity (>500-fold). He later completed a 3 year postdoctoral fellowship at The University of California where he traveled abroad to evaluate methods to mitigate resistance mechanisms in insects, and to evaluate environmentally safe and people friendly insecticide formulations. He was fortunate as a Ph.D. and postgraduate scholar to work on projects funded from the National Institutes of Health and The Bill and Melinda Gates Foundation. After completing his academic career he welcomed a new career in the medical marijuana industry. He has served as a board member on the Association of California Cannabis Laboratories, founder of Delta-9 Technologies, and the lead scientist at CannaVest Corporation. His work has been published in several peer-reviewed scientific journals, covered on major news networks (CNN and ABC 10 San Diego News), and earned recognition in multiple Cannabis Cups (Amsterdam, Seattle, and Los Angeles)/Michigan “Green Cup” for the highest cannabidiol (CBD) concentrates.



Greg Waterbury Bio



Greg Waterbury is the project and laboratory manager at CannaVest Corp possessing a laboratory and facility oriented background with over twenty years of experience in many aspects of life sciences. Known for effectiveness in start-ups, facility capital improvement, and consolidations. Recognized as an effective and motivational cross function team player with a consistent track record. With experience in biotechnology start-ups and early growth phases of company development, Greg also has a solid basic science background in molecular/cellular biology and genomics. Most recently Greg held project manager and facility manager positions at Life Technologies, Carlsbad California. He was employed at the Howard Hughes Medical Institute, Yale School of Medicine for seven years. Initially, he was a member of a laboratory that investigated and characterized genetic mutations which cause human adult polycystic kidney disease. He then went to work in the laboratory of Dr. Charles Janeway Jr. as part of research team, which investigated the role of the development of the T-Cell. While there, the lab discovered the first Toll-like receptor, (TLR4) an innate immunity receptor, which signals activation of adaptive immunity. He is a contributing author on over a dozen peer-reviewed publications.

http://www.cannavestlabs.com/?page_id=14